GLP-1 Weight Loss Drugs: Comparing Ozempic to New Market Leaders
Revolutionizing Obesity Treatment: The Rise of GLP-1 Receptor Agonists in Weight Loss The advent of glucagon-like peptide-1 (GLP-1) receptor agonists has redefined the pharmacological landscape of obesity management. Among these, Ozempic (semaglutide) has emerged as a frontrunner, demonstrating robust efficacy in sustained weight reduction through appetite suppression and metabolic modulation. However, the market is now … Read more